Addition of Metformin to Liraglutide, A GLP-1 Receptor Agonist, Improves Glycemic Control in Patients with Type 2 Diabetes Mellitus
Journal Title: Journal of Diabetes and Obesity - Year 2016, Vol 4, Issue 1
Abstract
Background: The maximum permissible dose of liraglutide, a GLP-1 receptor agonist, under the Japanese Heath Insurance system is 0.9 mg/day. We determined the effects of adding metformin to liraglutide therapy in Japanese patients with type 2 diabetes. Material and Methods: This observational retrospective study included 47 patients with type 2 diabetes who were treated with liraglutide alone or in combination with sulfonylureas. Metformin was added at a dose ranging from 250 to 500 mg/day based on inadequate glycemic control. Liraglutide and metformin doses were converted from mg/day to mg/kg body weight/day before analysis of the correlation between the dose and changes in glycated hemoglobin (HbA1c) and body mass index (BMI). Results: Both HbA1c and BMI decreased significantly after 24 weeks of the combination treatment. Mild gastrointestinal adverse events were reported by 21% of the patients. Only the dose of metformin, but not that of liraglutide, expressed in mg/kg body weight was correlated significantly with decrease in HbA1c and BMI. Conclusions: The addition of metformin to the maximum permissible dose of liraglutide helps secure glycemic control and reduce BMI in Japanese patients with type 2 diabetes who exhibit inadequate response to liraglutide.
Authors and Affiliations
Masao Toyoda
Keywords
Related Articles
- EP ID EP417851
- DOI 10.15436/2376-0494.17.1300
- Views 101
- Downloads 0
Effect of Bariatric Surgery on Glycemic Control in a Military Training Facilitytary Training Facility
Background: The objective of the study was to evaluate the effects of gastric bypass surgery on diabetic and pre-diabetic patients. Outcome variables were diabetic status, BMI, and if patients were able to discontinue pr...
Potential of Rubus Ulmifolius Schott Supplementation in the Attenuation of Sucrose-Induced Hyperglycemia, Dyslipidemia and Liver Oxidative Damage in Rats
Metabolic syndrome is associated with several disorders, including hypertension, diabetes, hyperlipidemia as well as cardiovascular diseases and stroke. The purpose of the present study was to investigate the preventive...
Exercise Intervention Improves the Metabolic Profile and Body Composition of Southwestern American Indian Adolescents
Introduction/Purpose: The Southwestern American Indian population carries a high prevalence of metabolic syndrome and obesity, placing this group at higher risk than the general population for developing early type 2 dia...
Integration of OMICS Data for Obesity
Introduction: Obesity is a multifactorial condition that results from the interactions among genetic, dietary, environmental, and lifestyle factors. In our study, we have employed a novel integrative approach to identify...
Relationships between Weight, Adiposity, Functional Status, and Left Ventricle Characteristics in Overweight and Obese Patients with Heart Failure
Aims: This study was conducted to examine the relationship between adiposity and functional status (i.e. peak oxygen consumption [VO2max]), and left ventricular (LV) structural characteristics (i.e., LV ejection fraction...